Leap Therapeutics Inc diskutieren
Leap Therapeutics Inc.
WKN: A3EMJP / Symbol: LPTX / Name: Leap Therapeutics / Aktie / Micro Cap /
2,20 €
-0,92 %
Leap Therapeutics, Inc. (NASDAQ: LPTX) had its price target lowered by analysts at Mizuho from $3.00 to $2.00. They now have a "buy" rating on the stock.
Ratings data for LPTX provided by MarketBeat
Leap Therapeutics, Inc. (NASDAQ: LPTX) had its "buy" rating re-affirmed by analysts at Mizuho. They now have a $2.00 price target on the stock.
Ratings data for LPTX provided by MarketBeat
Leap Therapeutics, Inc. (NASDAQ: LPTX) had its price target raised by analysts at HC Wainwright to $7.00. They now have a "buy" rating on the stock.
Ratings data for LPTX provided by MarketBeat
Leap Therapeutics, Inc. (NASDAQ: LPTX) had its price target lowered by analysts at Raymond James from $18.50 to $17.50. They now have an "outperform" rating on the stock.
Ratings data for LPTX provided by MarketBeat
Leap Therapeutics, Inc. (NASDAQ: LPTX) had its price target lowered by analysts at Mizuho from $20.00 to $12.00. They now have a "buy" rating on the stock.
Ratings data for LPTX provided by MarketBeat
Leap Therapeutics, Inc. (NASDAQ: LPTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Ratings data for LPTX provided by MarketBeat
Leap Therapeutics, Inc. (NASDAQ: LPTX) had its price target lowered by analysts at HC Wainwright from $7.00 to $5.50. They now have a "buy" rating on the stock.
Ratings data for LPTX provided by MarketBeat
Neueste Beiträge
Jefferies_Financial_ in Abercrombie + Fitch A diskutieren, Abercrombie + Fitch A